The primary objective of the clinical trial portion of this study is to assess whether an individualized dietary plan based on a commercial food sensitivity assay provides specific benefit in a randomized controlled trial in adults with irritable bowel syndrome (IBS).
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Irritable Bowel Syndrome Global Improvement Scale (IBS-GIS)
Timeframe: Baseline
Irritable Bowel Syndrome Global Improvement Scale (IBS-GIS)
Timeframe: 4 weeks
Irritable Bowel Syndrome Global Improvement Scale (IBS-GIS)
Timeframe: 8 weeks